These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38342741)

  • 21. Association between Lipid-Lowering Drugs and Traumatic Subdural Hemorrhage: A Mendelian Randomization Study.
    Chen K; Li H; Chen Y; Huang H; Wei L
    J Integr Neurosci; 2024 Apr; 23(4):76. PubMed ID: 38682216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene polymorphism and frequencies of the NPC1L1 gene (rs2072183, rs217434 and rs217428) in Japanese patients with dyslipidemia.
    Kashiwabara Y; Kobayashi Y; Koba S; Kohyama N; Ohbayashi M; Murayama JI; Hirano T; Kobayashi Y; Yamamoto T
    J Clin Pharm Ther; 2014 Oct; 39(5):551-4. PubMed ID: 24861377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between lipid-lowering drugs and pregnancy and perinatal outcomes: a Mendelian randomization study.
    Wang R; Zhao J; Li L; Huo Y
    J Hypertens; 2024 Apr; 42(4):727-734. PubMed ID: 38230624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using genetics to explore whether the cholesterol-lowering drug ezetimibe may cause an increased risk of cancer.
    Kobberø Lauridsen B; Stender S; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
    Int J Epidemiol; 2017 Dec; 46(6):1777-1785. PubMed ID: 29106532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The causal relationship between gut microbiota and biliary tract cancer: comprehensive bidirectional Mendelian randomization analysis.
    Wang K; Wang S; Qin X; Chen Y; Chen Y; Wang J; Zhang Y; Guo Q; Zhou C; Zou D
    Front Cell Infect Microbiol; 2024; 14():1308742. PubMed ID: 38558852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ezetimibe restores biliary cholesterol excretion in mice expressing Niemann-Pick C1-Like 1 only in liver.
    Tang W; Jia L; Ma Y; Xie P; Haywood J; Dawson PA; Li J; Yu L
    Biochim Biophys Acta; 2011 Sep; 1811(9):549-55. PubMed ID: 21683156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.
    Zambrano T; Saavedra N; Lanas F; Caamaño J; Salazar LA
    Mol Diagn Ther; 2015 Feb; 19(1):45-52. PubMed ID: 25589339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels.
    Xie P; Zhu H; Jia L; Ma Y; Tang W; Wang Y; Xue B; Shi H; Yu L
    Atherosclerosis; 2014 Dec; 237(2):609-17. PubMed ID: 25463095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Niemann-Pick C1-Like 1 inhibitors for reducing cholesterol absorption.
    Zhang R; Liu W; Zeng J; Meng J; Jiang H; Wang J; Xing D
    Eur J Med Chem; 2022 Feb; 230():114111. PubMed ID: 35063734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice.
    Xie P; Jia L; Ma Y; Ou J; Miao H; Wang N; Guo F; Yazdanyar A; Jiang XC; Yu L
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):920-5. PubMed ID: 23471229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and prognostic significance of Niemann-Pick C1-Like 1 in colorectal cancer: a retrospective cohort study.
    Kwon RJ; Park EJ; Lee SY; Lee Y; Hwang C; Kim C; Cho YH
    Lipids Health Dis; 2021 Sep; 20(1):104. PubMed ID: 34511128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of lipid-modifying therapy with risk of obstructive sleep apnea: A drug-target mendelian randomization study.
    Zou J; Qi S; Sun X; Zhang Y; Wang Y; Li Y; Zhao ZH; Lei D
    Toxicol Appl Pharmacol; 2024 Apr; 485():116909. PubMed ID: 38521370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study.
    Li N; Zhang X; Zhang M; Wu L; Li C; Pan Y; Wang W; Ji J; Zheng D
    Atherosclerosis; 2023 Mar; 369():9-16. PubMed ID: 36827905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Association between Circulating Lipids and Female Infertility Risk: A Univariable and Multivariable Mendelian Randomization Analysis.
    Zhu X; Hong X; Wu J; Zhao F; Wang W; Huang L; Li J; Wang B
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma lipid levels and risk of retinal vascular occlusion: A genetic study using Mendelian randomization.
    Zheng C; Lin Y; Jiang B; Zhu X; Lin Q; Luo W; Tang M; Xie L
    Front Endocrinol (Lausanne); 2022; 13():954453. PubMed ID: 36299452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic Niemann-Pick C1-Like 1 exacerbates non-alcoholic fatty liver disease by re-absorbing specific biliary oxysterols.
    Yamanashi Y; Takada T; Tanaka Y; Ogata Y; Toyoda Y; Ito SM; Kitani M; Oshida N; Okada K; Shoda J; Suzuki H
    Biomed Pharmacother; 2022 Dec; 156():113877. PubMed ID: 36270257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The c.-133A > G polymorphism in NPC1L1 gene influences the efficacy of ezetimibe monotherapy on apolipoprotein A1 in hyperlipidemic patients.
    Zsíros N; Bodor M; Varga V; Berta E; Balogh I; Seres I; Paragh G; Harangi M
    Pharmazie; 2014 Jun; 69(6):424-9. PubMed ID: 24974575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Niemann-pick C1-like 1 mediates alpha-tocopherol transport.
    Narushima K; Takada T; Yamanashi Y; Suzuki H
    Mol Pharmacol; 2008 Jul; 74(1):42-9. PubMed ID: 18403720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.
    Davis HR; Veltri EP
    J Atheroscler Thromb; 2007 Jun; 14(3):99-108. PubMed ID: 17587760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of lipid-lowering drugs with osteoarthritis outcomes from a drug-target Mendelian randomization study.
    Ma W; Chen H; Zhang Z; Xiong Y
    PLoS One; 2024; 19(2):e0293960. PubMed ID: 38416763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.